Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1
- PMID: 21062285
- DOI: 10.1111/j.1471-4159.2010.07098.x
Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1
Abstract
TAR DNA-binding protein-43 (TDP-43) proteinopathy has been linked to several neurodegenerative diseases, such as frontotemporal lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis. Phosphorylated and ubiquitinated TDP-43 C-terminal fragments have been found in cytoplasmic inclusions in frontotemporal lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis patients. However, the factors and pathways that regulate TDP-43 aggregation are still not clear. We found that the C-terminal 15 kDa fragment of TDP-43 is sufficient to induce aggregation but the aggregation phenotype is modified by additional sequences. Aggregation is accompanied by phosphorylation at serine residues 409/410. Mutation of 409/410 to phosphomimetic aspartic acid residues significantly reduces aggregation. Inhibition of either proteasome or autophagy dramatically increases TDP-43 aggregation. Furthermore, TDP-43 aggregates colocalize with markers of autophagy and the adaptor protein p62/SQSTM1. Over-expression of p62/SQSTM1 reduces TDP-43 aggregation in an autophagy and proteasome-dependent manner. These studies suggest that aggregation of TDP-43 C-terminal fragments is regulated by phosphorylation events and both the autophagy and proteasome-mediated degradation pathways.
© 2010 The Authors. Journal of Neurochemistry © 2010 International Society for Neurochemistry.
Similar articles
-
PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies.Autophagy. 2020 Aug;16(8):1396-1412. doi: 10.1080/15548627.2019.1686729. Epub 2019 Nov 5. Autophagy. 2020. PMID: 31690171 Free PMC article.
-
Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system.Neurosci Lett. 2010 Jan 18;469(1):112-6. doi: 10.1016/j.neulet.2009.11.055. Epub 2009 Nov 26. Neurosci Lett. 2010. PMID: 19944744
-
p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions.J Neurosci Res. 2012 Oct;90(10):2034-42. doi: 10.1002/jnr.23081. Epub 2012 Jun 5. J Neurosci Res. 2012. PMID: 22674379
-
[The molecular mechanisms of intracellular TDP-43 aggregates].Brain Nerve. 2009 Nov;61(11):1292-300. Brain Nerve. 2009. PMID: 19938686 Review. Japanese.
-
Impaired protein degradation in FTLD and related disorders.Ageing Res Rev. 2016 Dec;32:122-139. doi: 10.1016/j.arr.2016.04.008. Epub 2016 May 7. Ageing Res Rev. 2016. PMID: 27166223 Review.
Cited by
-
What we know about TMEM106B in neurodegeneration.Acta Neuropathol. 2016 Nov;132(5):639-651. doi: 10.1007/s00401-016-1610-9. Epub 2016 Aug 20. Acta Neuropathol. 2016. PMID: 27543298 Free PMC article. Review.
-
Expanding the TDP-43 Proteinopathy Pathway From Neurons to Muscle: Physiological and Pathophysiological Functions.Front Neurosci. 2022 Feb 3;16:815765. doi: 10.3389/fnins.2022.815765. eCollection 2022. Front Neurosci. 2022. PMID: 35185458 Free PMC article. Review.
-
Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal Ganglia.ASN Neuro. 2023 Jan-Dec;15:17590914231158218. doi: 10.1177/17590914231158218. ASN Neuro. 2023. PMID: 36890725 Free PMC article.
-
Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration.Neurotherapeutics. 2019 Jul;16(3):611-634. doi: 10.1007/s13311-019-00742-3. Neurotherapeutics. 2019. PMID: 31183763 Free PMC article. Review.
-
Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration.Mol Neurodegener. 2018 Feb 6;13(1):7. doi: 10.1186/s13024-018-0237-9. Mol Neurodegener. 2018. PMID: 29409526 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases